Trademark: 87554277
Status Date
Monday, March 15, 2021
Filing Date
Thursday, August 3, 2017
Published for Opposition
Tuesday, December 12, 2017
Abandoned Date
Monday, March 15, 2021
5 pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products, namely, EZH2 inhibitory drugs
Oct 19, 2022
Assignment Of Ownership Not Updated Automatically
Mar 15, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 15, 2021
Abandonment - No Use Statement Filed
Aug 15, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 14, 2020
Sou Extension 5 Granted
Jul 24, 2020
Sou Extension 5 Filed
Aug 12, 2020
Case Assigned To Intent To Use Paralegal
Jul 24, 2020
Teas Extension Received
Jan 29, 2020
Notice Of Approval Of Extension Request E-Mailed
Jan 27, 2020
Sou Extension 4 Granted
Jan 27, 2020
Sou Extension 4 Filed
Jan 27, 2020
Teas Extension Received
Jul 24, 2019
Notice Of Approval Of Extension Request E-Mailed
Jul 22, 2019
Sou Extension 3 Granted
Jul 22, 2019
Sou Extension 3 Filed
Jul 22, 2019
Teas Extension Received
Jan 17, 2019
Notice Of Approval Of Extension Request E-Mailed
Jan 15, 2019
Sou Extension 2 Granted
Jan 15, 2019
Sou Extension 2 Filed
Jan 15, 2019
Teas Extension Received
Jun 16, 2018
Notice Of Approval Of Extension Request E-Mailed
Jun 14, 2018
Sou Extension 1 Granted
Jun 14, 2018
Sou Extension 1 Filed
Jun 14, 2018
Teas Extension Received
Feb 6, 2018
Noa E-Mailed - Sou Required From Applicant
Dec 12, 2017
Official Gazette Publication Confirmation E-Mailed
Dec 12, 2017
Published For Opposition
Nov 22, 2017
Notification Of Notice Of Publication E-Mailed
Nov 6, 2017
Approved For Pub - Principal Register
Nov 6, 2017
Assigned To Examiner
Aug 8, 2017
New Application Office Supplied Data Entered In Tram
Aug 7, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
